# Bios Life

Source: https://onco.cc/companies/bios-life/  
OnCo record `bios-life` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Bios Life runs a virtual clinic for people who have finished cancer treatment or who carry a high inherited risk: a care team watches their risk over time and uses AI models to decide which scan or test should come next and when.

## Summary

Bios Life describes itself as an AI-native cancer surveillance company. It combines multi-modality foundation models with direct patient care, delivered virtually by licensed care teams across the United States, to personalise screening for people at high risk and follow-up for cancer survivors. It emerged from stealth in August 2026 with USD 25 million in seed financing led by Redmile, Vsquared Ventures and Kindred Capital, and announced a multi-year alliance with Tempus giving it access to de-identified multimodal oncology datasets to train and validate its models, together with genetic screening through Ambry Genetics, a Tempus company. Its co-founders are chief executive Ryan Richardson and Zach Taylor, both formerly of BioNTech, and chief medical officer Logan Frank, a radiologist. The company said its platform would launch in the US in the second half of 2026.

## Fields

- Kind: Company
- Last checked: 2026-10-29
- HQ: Boston, MA
- Type: ai-software
- Website: https://www.bioslife.ai/

## Notes

- Founding year not stated. HQ is the Boston dateline of the launch release; the company website gives no address. Bios Life is a surveillance and care service, not a blood test for many cancers, so it is not counted as multi-cancer early detection. No outcome data had been published at the time of writing.

## Sources

- Official website: https://www.bioslife.ai/
- Launch release and Tempus alliance, August 2026: https://www.einpresswire.com/article/933138397/bios-life-emerges-from-stealth-with-25m-and-partners-with-tempus-to-personalize-cancer-screening-and-surveillance

## Connected records

- fronts: [AI & Computation](https://onco.cc/fronts/ai-computation/), [Early Detection & Screening](https://onco.cc/fronts/early-detection/)
- technologies: [Survivorship care and late-effects surveillance](https://onco.cc/technologies/survivorship-care-plan/), [Telehealth and hospital-at-home in oncology](https://onco.cc/technologies/telehealth-oncology/)

---
JSON: https://onco.cc/api/v1/entities/bios-life.json